Filter by Lead Doctor (All Doctors) Przemyslaw Twardowski, M.D.Jennifer Linehan, M.D.Przemyslaw Twardowski, M.D. Title Physician Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer NCT ID : 05803941 Phase : 4 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D. Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents (EvoPAR-PR01) NCT ID : 06120491 Phase : 3 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D. A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer NCT ID : 05483868 Phase : 1 Location : Saint John's Cancer Institute Jennifer Linehan, M.D. Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer (Solar-Recur) NCT ID : 06235151 Phase : 3 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D. Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer NCT ID : 03972657 Protocol Number : R5678-ONC-1879 Phase : 1/2 Location : Saint John's Cancer Institute Przemyslaw Twardowski, M.D.
